Bio-Matrix Scientific Group Inc. (PINK: BMSN) shares saw a huge rally on Monday. The stock rose 85% to finish the day at $0.0370 on above average volume. The stock is up 270% in the last three trading sessions.
So what sparked the huge rally on Monday?
Bio-Matrix shares surged on Monday after the biotechnology company announced that it formed a new subsidiary, Regen BioPharma Inc.
BMSN’s new subsidiary has developed a vertically-integrated structure and is focused on acquiring patents, performing accelerating preclinical and clinical development and licensing or selling technology developed to large pharma companies in the area of stem cells.
Regen, to date, has reviewed over 20,000 U.S. issued patents covering stem cell related subject matter. The company has already created a list of 30 promising technologies for rapid commercialization and is in talks to license a number of these technologies.
David R. Koos, Chairman and CEO of Bio-Matrix Scientific Group, said that BMSN is assembling the team and capabilities to in-license and evaluate technologies rapidly, then to develop the regulator package and initiate clinical trials.
Recent Comments